Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ANTHERA PHARMA
(NQ:
ANTH
)
0.6080
USD
+0.0280 (+4.83%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Stories about ANTHERA PHARMA
< Previous
1
2
3
4
Next >
Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
May 07, 2013
Anthera Pharmaceuticals (Nasdaq: ANTH ), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced that additional data from its Phase...
Read More
category
Benzinga
,
ANTH
,
Hot
, and 2 more.
from
Latest Articles from Benzinga.com
Anthera Pharma (ANTH) Files $100M Mixed Shelf
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8237843 for the full story.
Read More
from
StreetInsider.com News Articles
Lupus drug developer Anthera refinances $20M in debt, lands $18.5M funding commitment
April 05, 2013
Anthera Pharmaceuticals Inc. refinanced existing debt through a $20 million credit facility, the company said late Friday. The Hayward-based inflammatory disease drug developer (NASDAQ: ANTH), which...
Read More
from
National Business News - Local Business News | bizjournals
Anthera Pharmaceuticals, Inc. (ANTH) Tops Q4 EPS by 4c
March 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8212730 for the full story.
Read More
from
StreetInsider.com News Articles
Notable Analyst Rating Changes 03/05: (MTG) (APOL) (YHOO) Upgraded; (WPZ) (AAPL) (IPXL) Downgraded
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8156605 for the full story.
Read More
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 03/05: (ZOLT) (APP) (MTG) Higher; (IPXL) (JCP) (FR) Lower (more...)
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8156208 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Jefferies Initiates Anthera Pharmaceuticals at Buy on Blisibimod Outlook
March 05, 2013
Jefferies initiated coverage on Anthera Pharmaceuticals (NASDAQ: ANTH ) with a Buy rating and a $2.00 price target. Jefferies noted, "Despite conducting a well randomized Phase II trial, and improving...
Read More
category
Benzinga
,
ANTH
,
Initiation
, and 3 more.
from
Latest Articles from Benzinga.com
Jefferies Starts Anthera Pharma (ANTH) at Buy, $2 PT
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8155131 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera Pharma (ANTH) Prices 60.6M Offering at 66c/Share
January 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8031679 for the full story.
Read More
from
StreetInsider.com News Articles
Leerink Swann Resumes Anthera Pharma (ANTH) at Outperform
November 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7869712 for the full story.
Read More
from
StreetInsider.com News Articles
Pre-Open Movers 11/01: (JDAS) (ELLI) (FIRE) Higher; (ABMD) (ZUMZ) (AVP) Lower (more...)
November 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7834487 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera Pharm (ANTH) Pops on News of Poster
November 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7834432 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera Pharmaceuticals, Inc. (ANTH) Posts Q3 Loss of 17c/Share
October 24, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7816256 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera Pharmaceuticals To Submit Trial Protocols
September 18, 2012
Anthera Pharmaceuticals Inc. (Nasdaq: ANTH) will submit Phase 3 trial protocols for its lupus treatment blisibimod lifting the stock price 13 cents to $1.18. ...
Read More
from
MarketMinute.com Stock News
Mixed Open As Investors Monitor Crude Oil Prices
September 18, 2012
The markets opened mixed with the Dow adding 6 points to 13,559 while Nasdaq eased a point to 3177 as investors monitored crude oil prices.
Read More
category
Market News
from
MarketMinute.com Market Updates
Anthera (ANTH) Completes End of Phase 2 Talks w/ FDA for Blisibimod; to Submit Phase 3 Protocols
September 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7730075 for the full story.
Read More
from
StreetInsider.com News Articles
RA Capital Management Shows New 6.1% Stake in Anthera Pharmaceuticals (ANTH)
July 30, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7612771 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera Pharmaceuticals (ANTH) Completes 33 Million Share Offering; Exercise in Full of Over-Allotment Option
July 24, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7600807 for the full story.
Read More
from
StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 07/19: (MLNX) (PSDV) (SCSS) Higher; (IRG) (EDU) (WHX) Lower
July 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7591625 for the full story.
Read More
from
StreetInsider.com News Articles
Morning Movers 07/19: (PSDV) (MLNX) (EDU) (SCSS) Higher; (IRG) (ANTH) (WHX) (DCIX) Lower
July 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7591079 for the full story.
Read More
from
StreetInsider.com News Articles
Upbeat Earnings Lift Markets To Higher Open
July 19, 2012
Upbeat corporate earnings tempered a gain in jobless claims to lift the markets to a modestly higher open with the Dow adding 9 points to 12,918. Nasdaq rose 14 points to 2957.
Read More
category
Market News
from
MarketMinute.com Market Updates
Pre-Open Losers 7/19: (IRG) (GHL) (JCI) Lower (more...)
July 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7590808 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera (ANTH) Slammed After Pricing 33M Offering at Substantial Discount
July 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7590757 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera (ANTH) Prices 33M Offering at $1/Share
July 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7590743 for the full story.
Read More
from
StreetInsider.com News Articles
Stocks to watch Thursday: Libbey, J.M. Smucker
July 19, 2012
MarketWatch’s rundown of corporate headlines of interest to investors early Thursday.
Read More
category
Earnings
,
VZ
,
SCSS
, and 61 more.
from
MarketWatch
After-Hours Movers 07/18: (MLNX) (SCSS) (SWKS) (EBAY) (QCOM) (IBM) Higher; (DCIX) (ANTH) (NSPH) Lower
July 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7589562 for the full story.
Read More
from
StreetInsider.com News Articles
Anthera Pharma (ANTH) Announces Common Offering
July 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7589110 for the full story.
Read More
from
StreetInsider.com News Articles
Morning Movers 07/18: (SUPN) (GALE) (AIR) (APH) Higher; (ROVI) (WHX) (HHS) Lower
July 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7588047 for the full story.
Read More
from
StreetInsider.com News Articles
Upbeat Earnings Lift Markets To Higher Close
July 17, 2012
The markets closed higher with the Dow gaining 78 points to 12,805 as upbeat corporate earnings tempered disappointment that Federal Reserve Chairman failed to lower interest rates. Nasdaq climbed 13...
Read More
category
Market News
from
MarketMinute.com Market Updates
Anthera Reports Positive Results
July 17, 2012
Anthera Pharmaceuticals Inc. (Nasdaq: ANTH) announced reported positive results from a Phase 2b PEARL-SC trial of its systemic lupus erythematosus treatment blisibimod. The stock price climbed 27 cents...
Read More
from
MarketMinute.com Stock News
< Previous
1
2
3
4
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.